Progress in the role of farnesoid X receptor in metabolic regulation and tumor cell proliferation.
- Author:
Yang XIE
1
;
Xue-Yan ZHOU
;
Hai-Ping HAO
;
Guang-Ji WANG
Author Information
1. State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China. guangjiwang@hotmail.com.
- Publication Type:Journal Article
- MeSH:
Cell Proliferation;
Homeostasis;
Humans;
Neoplasms;
metabolism;
Receptors, Cytoplasmic and Nuclear;
metabolism;
Transcription Factors
- From:
Acta Physiologica Sinica
2014;66(2):252-258
- CountryChina
- Language:Chinese
-
Abstract:
Farnesoid X receptor (FXR) is a ligand-activated transcriptional factor belonged to the superfamily of nuclear receptors. In the past decades, FXR has been found with important roles in the regulation of metabolic homeostasis of bile acids, cholesterol, lipids and carbohydrates. Recent studies further demonstrate the potential protective effect of FXR against metabolic diseases, such as hyperglycemia and hyperlipidemia, as well as inflammatory bowel diseases (IBD). In addition, FXR plays an essential role in liver regeneration, tumor cell proliferation and apoptosis. However, the role of FXR in the development of tumor is still obscure and even with discrepancy. This article reviews the function of FXR in metabolic regulation and recent progress in basic, clinical and pharmacological researches related to tumor cell proliferation involving FXR.
